Pharma Companies Strategies, Key Facts & Figures
“Pharma Companies Strategies – Key Facts & Challenges – 2011 Edition” provides a fact-based analysis of the evolution of the pharmaceutical market and evaluates the strategy and performance of 35 leading pharmaceutical companies.
The author shares his strategic vision of where the pharmaceutical is headed and the strategies that can be adopted – with a particular emphasis on the strategic priorities and the corresponding performance of Big Pharma Companies and Mid Pharma Companies.
The key facts and figures corresponding to each of the 35 analyzed pharmaceutical companies have been summarized on one-page identity cards, providing a concise, powerful, snapshot of each firm for easy review and comparison.
Section 1: Pharma Market Insight 2010 analyzes the three following key points:
- The pharma market structure
- The pharma market drivers and limiters
- The strategic options for leading pharma companies
Section 2: Pharma Companies Strategy & Performance 2010 evaluates whether the size of companies has an impact on their performance and their strategic orientation, through the analysis of seven criteria:
- Strategic segments coverage
- Product portfolio structure
- R&D investments & activities
- Geographical coverage
- Business development
- Key financial data (revenues and profits)
- Strategic priorities
Section 3: Leading Pharma Companies at a Glance provides a one-page strategic identity card for 35 leading pharma companies
About the author
Jean-Michel Peny is President of the Strategy and Management consulting firm Smart Pharma Consulting, Director of Smart Pharma Institute of Management, Lecturer in Pharmaceutical Strategy and Marketing at the ESCP Europe and ESSEC Business Schools, the Faculty of Pharmaceutical Sciences (Paris XI) and the Faculty of Medicine (Paris VI).
Prior to founding Smart Pharma Consulting in 2001, Jean-Michel advised many of the leading global pharmaceutical companies during his 19 years as a Strategy and Management consultant with Bain & Co, AT Kearney, Arthur D.Little, and ISO HealthCare Group. Prior to his consulting career, Jean-Michel was a General Manager in the pharmaceutical industry for over seven years with Servier and Novartis.
Jean-Michel holds a doctorate in Pharmaceutical Sciences from the University of Nantes, a master in International Business from the University of Lyon III and an MBA from HEC Business School.
He is a former affiliate professor at HEC Business School and has published over 40 articles on business issues related to the pharmaceutical industry, as well as several books: "Pharma Market Insight & Strategy" (2012), "Pharma Companies Strategies, Key Facts & Figures" (2011), “Pharma Market Insights” (2010), “Pharma Marketing Tool Box” (2008), and co-authored "Le marketing du médicament en question(s)" (Vuibert-2008).
Wire-bound handbook: 124 pages
Publisher: Smart Pharma Consulting (October 2011)
Price: 150 € (incl. tax)